Genflow Biosciences (LON:GENF) Stock Price Down 6.3% – Time to Sell?

Genflow Biosciences plc (LON:GENF)’s stock price traded down 6.3% during mid-day trading on Wednesday . The company traded as low as GBX 1.85 and last traded at GBX 1.85. 14,538 shares changed hands during trading, a decline of 99% from the average session volume of 2,700,749 shares. The stock had previously closed at GBX 1.98.

Genflow Biosciences Trading Down 6.3%

The business has a fifty day moving average of GBX 1.94 and a 200-day moving average of GBX 1.78. The firm has a market cap of £9.13 million, a PE ratio of -3.69 and a beta of 2.24.

Genflow Biosciences Company Profile

Genflow Biosciences plc is a UK based biotech company with R&D facilities in Belgium and a US office in Cambridge, MA, driven by one mission: to deliver therapeutics that potentially halt or slow the ageing process in humans and dogs.
The company’s lead compound works through the delivery of a centenarian variant of the SIRT6 gene and has yielded promising preclinical results.